88 related articles for article (PubMed ID: 21156227)
1. Gene dosage effects in chronic lymphocytic leukemia.
Sellmann L; Scholtysik R; Kreuz M; Cyrull S; Tiacci E; Stanelle J; Carpinteiro A; Nückel H; Boes T; Gesk S; Siebert R; Klein-Hitpass L; Dührsen U; Dürig J; Küppers R
Cancer Genet Cytogenet; 2010 Dec; 203(2):149-60. PubMed ID: 21156227
[TBL] [Abstract][Full Text] [Related]
2. Integrated genomic profiling of chronic lymphocytic leukemia identifies subtypes of deletion 13q14.
Ouillette P; Erba H; Kujawski L; Kaminski M; Shedden K; Malek SN
Cancer Res; 2008 Feb; 68(4):1012-21. PubMed ID: 18281475
[TBL] [Abstract][Full Text] [Related]
3. Bulky lymphadenopathy with poor clinical outcome is associated with ATM downregulation in B-cell chronic lymphocytic leukemia patients irrespective of 11q23 deletion.
Joshi AD; Dickinson JD; Hegde GV; Sanger WG; Armitage JO; Bierman PJ; Bociek RG; Devetten MP; Vose JM; Joshi SS
Cancer Genet Cytogenet; 2007 Jan; 172(2):120-6. PubMed ID: 17213020
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of ATM and TP53 deletions in Chinese patients with chronic lymphocytic leukemia.
Xu W; Li JY; Wu YJ; Yu H; Shen QD; Li L; Fan L; Qiu HX
Leuk Res; 2008 Jul; 32(7):1071-7. PubMed ID: 18035414
[TBL] [Abstract][Full Text] [Related]
5. Translocations as a mechanism for homozygous deletion of 13q14 and loss of the ATM gene in a patient with B-cell chronic lymphocytic leukemia.
Herholz H; Kern W; Schnittger S; Haferlach T; Dicker F; Haferlach C
Cancer Genet Cytogenet; 2007 Apr; 174(1):57-60. PubMed ID: 17350468
[TBL] [Abstract][Full Text] [Related]
6. ATM, CTLA4, MNDA, and HEM1 in high versus low CD38 expressing B-cell chronic lymphocytic leukemia.
Joshi AD; Hegde GV; Dickinson JD; Mittal AK; Lynch JC; Eudy JD; Armitage JO; Bierman PJ; Bociek RG; Devetten MP; Vose JM; Joshi SS
Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5295-304. PubMed ID: 17875758
[TBL] [Abstract][Full Text] [Related]
7. Increased transferrin receptor expression following 11q23 deletion as a mechanism of malignant progression in chronic lymphocytic leukemia.
Shackelford RE; Bhalodia AR; Cotelingam JD; Veillon DM; Lowery-Nordberg M
Med Hypotheses; 2006; 66(3):509-12. PubMed ID: 16326028
[TBL] [Abstract][Full Text] [Related]
8. Molecular and transcriptional characterization of 17p loss in B-cell chronic lymphocytic leukemia.
Fabris S; Mosca L; Todoerti K; Cutrona G; Lionetti M; Intini D; Matis S; Colombo M; Agnelli L; Gentile M; Spriano M; Callea V; Festini G; Molica S; Lambertenghi Deliliers G; Morabito F; Ferrarini M; Neri A
Genes Chromosomes Cancer; 2008 Sep; 47(9):781-93. PubMed ID: 18521849
[TBL] [Abstract][Full Text] [Related]
9. Presence of heterozygous ATM deletion may not be critical in the primary response of chronic lymphocytic leukemia cells to fludarabine.
Cejkova S; Rocnova L; Potesil D; Smardova J; Novakova V; Chumchalova J; Zezulkova D; Borsky M; Doubek M; Brychtova Y; Pospisilova S; Klabusay M; Mayer J; Trbusek M
Eur J Haematol; 2009 Feb; 82(2):133-42. PubMed ID: 19018867
[TBL] [Abstract][Full Text] [Related]
10. [Prognostic significance of p53 and ATM gene deletion in patients with chronic lymphocytic leukemia].
Xu W; Li JY; Li L; Wu YJ; Yu H; Shen QD; Qiu HX
Zhonghua Xue Ye Xue Za Zhi; 2008 Jul; 29(7):450-3. PubMed ID: 19035176
[TBL] [Abstract][Full Text] [Related]
11. Identification of chromosomal abnormalities relevant to prognosis in chronic lymphocytic leukemia using multiplex ligation-dependent probe amplification.
Stevens-Kroef M; Simons A; Gorissen H; Feuth T; Weghuis DO; Buijs A; Raymakers R; Geurts van Kessel A
Cancer Genet Cytogenet; 2009 Dec; 195(2):97-104. PubMed ID: 19963108
[TBL] [Abstract][Full Text] [Related]
12. Late appearance of the 11q22.3-23.1 deletion involving the ATM locus in B-cell chronic lymphocytic leukemia and related disorders. Clinico-biological significance.
Cuneo A; Bigoni R; Rigolin GM; Roberti MG; Bardi A; Cavazzini F; Milani R; Minotto C; Tieghi A; Della Porta M; Agostini P; Tammiso E; Negrini M; Castoldi G
Haematologica; 2002 Jan; 87(1):44-51. PubMed ID: 11801464
[TBL] [Abstract][Full Text] [Related]
13. Loss of MIR15A and MIR16-1 at 13q14 is associated with increased TP53 mRNA, de-repression of BCL2 and adverse outcome in chronic lymphocytic leukaemia.
Lin K; Farahani M; Yang Y; Johnson GG; Oates M; Atherton M; Douglas A; Kalakonda N; Pettitt AR
Br J Haematol; 2014 Nov; 167(3):346-55. PubMed ID: 25040181
[TBL] [Abstract][Full Text] [Related]
14. Identification of acquired copy number alterations and uniparental disomies in cytogenetically normal acute myeloid leukemia using high-resolution single-nucleotide polymorphism analysis.
Bullinger L; Krönke J; Schön C; Radtke I; Urlbauer K; Botzenhardt U; Gaidzik V; Carió A; Senger C; Schlenk RF; Downing JR; Holzmann K; Döhner K; Döhner H
Leukemia; 2010 Feb; 24(2):438-49. PubMed ID: 20016533
[TBL] [Abstract][Full Text] [Related]
15. A new minimal deleted region at 11q22.3 reveals the importance of interpretation of diminished FISH signals and the choice of probe for ATM deletion screening in chronic lymphocytic leukemia.
Gardiner A; Parker H; Glide S; Mould S; Robinson H; Tracy I; Stankovic T; Oscier D; Strefford J
Leuk Res; 2012 Mar; 36(3):307-10. PubMed ID: 21955805
[TBL] [Abstract][Full Text] [Related]
16. Cryptic deletion involving the ATM locus at 11q22.3 approximately q23.1 in B-cell chronic lymphocytic leukemia and related disorders.
Eclache V; Caulet-Maugendre S; Poirel HA; Djemai M; Robert J; Lejeune F; Raphaël M
Cancer Genet Cytogenet; 2004 Jul; 152(1):72-6. PubMed ID: 15193446
[TBL] [Abstract][Full Text] [Related]
17. New insights into the pathogenesis of chronic lymphocytic leukemia.
Klein U; Dalla-Favera R
Semin Cancer Biol; 2010 Dec; 20(6):377-83. PubMed ID: 21029776
[TBL] [Abstract][Full Text] [Related]
18. Frequent occurrence of uniparental disomy in colorectal cancer.
Andersen CL; Wiuf C; Kruhøffer M; Korsgaard M; Laurberg S; Ørntoft TF
Carcinogenesis; 2007 Jan; 28(1):38-48. PubMed ID: 16774939
[TBL] [Abstract][Full Text] [Related]
19. Imperfect correlation between p53 dysfunction and deletion of TP53 and ATM in chronic lymphocytic leukaemia.
Carter A; Lin K; Sherrington PD; Atherton M; Pearson K; Douglas A; Burford A; Brito-Babapulle V; Matutes E; Catovsky D; Pettitt AR
Leukemia; 2006 Apr; 20(4):737-40. PubMed ID: 16437137
[No Abstract] [Full Text] [Related]
20. Analysis of 11q22-q23 deletion target genes in B-cell chronic lymphocytic leukaemia: evidence for a pathogenic role of NPAT, CUL5, and PPP2R1B.
Kalla C; Scheuermann MO; Kube I; Schlotter M; Mertens D; Döhner H; Stilgenbauer S; Lichter P
Eur J Cancer; 2007 May; 43(8):1328-35. PubMed ID: 17449237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]